These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36145664)

  • 1. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates.
    Tikum AF; Nambisan AK; Ketchemen JP; Babeker H; Khan MN; Torlakovic EE; Fonge H
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft.
    Hartimath SV; El-Sayed A; Makhlouf A; Bernhard W; Gonzalez C; Hill W; Parada AC; Barreto K; Geyer CR; Fonge H
    Oncotarget; 2019 Feb; 10(10):1031-1044. PubMed ID: 30800216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of
    Hartimath SV; Alizadeh E; Solomon VR; Chekol R; Bernhard W; Hill W; Parada AC; Barreto K; Geyer CR; Fonge H
    J Nucl Med; 2019 Aug; 60(8):1103-1110. PubMed ID: 30655327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of
    Tikum AF; Ketchemen JP; Doroudi A; Nambisan AK; Babeker H; Njotu FN; Fonge H
    J Nucl Med; 2024 Feb; ():. PubMed ID: 38360051
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Chekol R; Solomon VR; Alizadeh E; Bernhard W; Fisher D; Hill W; Barreto K; DeCoteau JF; Parada AC; Geyer CR; Fonge H
    Oncotarget; 2018 Mar; 9(24):17117-17132. PubMed ID: 29682209
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Alizadeh E; Behlol Ayaz Ahmed K; Raja Solomon V; Gaja V; Bernhard W; Makhlouf A; Gonzalez C; Barreto K; Casaco A; Geyer CR; Fonge H
    Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimotuzumab Site-Specifically Labeled with
    Solomon VR; Barreto K; Bernhard W; Alizadeh E; Causey P; Perron R; Gendron D; Alam MK; Carr A; Geyer CR; Fonge H
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing
    Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA
    Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radiopharmaceutical [
    Tang Y; Hu Y; Liu W; Chen L; Zhao Y; Ma H; Yang J; Yang Y; Liao J; Cai J; Chen Y; Liu N
    Nucl Med Biol; 2019 Mar; 70():23-31. PubMed ID: 30826708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
    Al-Saden N; Lam K; Chan C; Reilly RM
    Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor uptake and tumor/blood ratios for [
    Al-Saden N; Cai Z; Reilly RM
    Nucl Med Biol; 2018 Dec; 67():43-51. PubMed ID: 30390575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody-Drug Conjugates.
    Azhdarinia A; Voss J; Ghosh SC; Simien JA; Hernandez Vargas S; Cui J; Yu WA; Liu Q; Carmon KS
    Mol Pharm; 2018 Jun; 15(6):2448-2454. PubMed ID: 29718672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
    Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM
    Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
    Chan C; Fonge H; Lam K; Reilly RM
    Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules.
    Garousi J; Andersson KG; Mitran B; Pichl ML; Ståhl S; Orlova A; Löfblom J; Tolmachev V
    Int J Oncol; 2016 Apr; 48(4):1325-32. PubMed ID: 26847636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer.
    Solomon VR; Alizadeh E; Bernhard W; Makhlouf A; Hartimath SV; Hill W; El-Sayed A; Barreto K; Geyer CR; Fonge H
    Sci Rep; 2020 Oct; 10(1):18549. PubMed ID: 33122707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near infrared fluorescence imaging of EGFR expression
    Bernhard W; El-Sayed A; Barreto K; Gonzalez C; Hill W; Parada AC; Fonge H; Geyer CR
    Oncotarget; 2018 Jan; 9(5):6213-6227. PubMed ID: 29464066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC).
    Kollmannsberger C; Schittenhelm M; Honecker F; Tillner J; Weber D; Oechsle K; Kanz L; Bokemeyer C
    Ann Oncol; 2006 Jun; 17(6):1007-13. PubMed ID: 16533873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
    Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
    Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.